BiotechTube

Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + Placebo

Phase 1Terminated
1 views this week 0 watching💤 Quiet
Interest: 21/100
21
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rotavirus

Conditions

Rotavirus

Trial Timeline

Jan 1, 2009 → Jan 1, 2010

NCT ID
NCT00836498

About Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + Placebo

Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + Placebo is a phase 1 stage product being developed by Merck for Rotavirus. The current trial status is terminated. This product is registered under clinical trial identifier NCT00836498. Target conditions include Rotavirus.

What happened to similar drugs?

1 of 13 similar drugs in Rotavirus were approved

Approved (1) Terminated (1) Active (11)
✅RotaTeq™ (V260) + DTP-IPVMerckApproved
❌Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)MerckPhase 3
🔄RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™MerckPhase 3
🔄Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered)MerckPhase 3
🔄RotaTeq (V260) + IPVMerckPhase 3
🔄Rotateq™ + Comparator: PlaceboMerckPhase 3
🔄Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 3

Hype Score Breakdown

Clinical
6
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00836498Phase 1Terminated

Competing Products

14 competing products in Rotavirus

See all competitors
ProductCompanyStageHype Score
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)MerckPhase 3
32
RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™MerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered)MerckPhase 3
40
RotaTeq (V260) + IPVMerckPhase 3
40
Rotateq™ + Comparator: PlaceboMerckPhase 3
40
RotaTeq™ (V260) + DTP-IPVMerckApproved
43
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 3
40
V260 + Placebo to V260 + OPV + DTaPMerckPhase 3
40
rotavirus vaccine, live, oral, pentavalent + PlaceboMerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo + Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 1
29
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: placebo + Comparator: Infanrix(tm) HexaMerckPhase 3
40
RotaTeq™ experimental formulation + RotaTeq™ existing formulationMerckPhase 3
40
Rotarix + RotaTeqMerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™) + Comparator: Comparator: Placebo (unspecified)MerckPhase 3
40